← Leaderboards
Kerstin Rebrin
Profusa, Inc.
$910,879
Attributed
$1,821,758
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.2M · FY2018–19$2M$1.5M$1M$500K$0
'18
'19
Funding mix
By agency
NIH$1,821,758 · 2
By mechanism
SB1$962,340 · 1
R44$859,418 · 1
Top collaborators
- Soya Gamsey2 shared
- Michael Salvatore Conte1 shared
Most similar at Profusa, Inc.
Same institution · by research overlap
- Natalie Ann Wisniewski$7,269,594
- Scott Nichols$1,395,103
- Soya Gamsey$481,170
- Janna Register$705,313
Others in their field
Other Emerging Leaders on “Quality Of Life”
- Marlene Ann Cooper · Harvard University D/B/A Harvard School Of Public Health$71,912,072
- Martha Hering · Westat, Inc.$57,098,843
- Susan Abushakra · Alzheon, Inc.$47,265,244
- Abraham Aizer Brody · New York University School Of Medicine$40,849,810
- Steven A. Ackerman · University Of Wisconsin-Madison$38,898,438
- Greg Yothers · University Of Chicago$35,003,821
Research focus
Quality Of LifeTissuesDesignOperative Surgical ProceduresSkinTechnologyChronicCostFamily SuidaeMonitorSensorSensor TechnologySmall Business Innovation Research GrantSubcutaneousAffectBaseBiomaterial CompatibilityCommercializationAdoptedEnsureHydrogelsInjectableBusinessesValidation
Grant awards (3)
Tissue Oxygen Monitoring in Peripheral Vascular Disease$859,418
R44 · FY2019 · HL · contact PI
Late stage development and preparation of a long-term non-enzymatic continuous glucose sensor for clinical trials$356,839
SB1 · FY2019 · DK
Late stage development and preparation of a long-term non-enzymatic continuous glucose sensor for clinical trials$605,501
SB1 · FY2018 · DK